Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-26-000704·T. Rowe Price Investment Management, Inc.
Schedule 13G ownership disclosure
Xenon Pharmaceuticals Inc
COMMON STOCK · CUSIP: 98420N105
Event date: 2026-10-31
- Filing-level shares
- 9,996,124
- Percent of class
- 10.3%
- T. Rowe Price Investment Management, Inc.
Shares: 9,996,124 · Class: 10.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-26-000704
- Form type
- SCHEDULE 13G/A
- Filer
- T. Rowe Price Investment Management, Inc.
- CIK
- CIK 1897612
- Filed
- Nov 06, 2026
- Reporting period
- Oct 31, 2026
- Description
- Schedule 13G beneficial ownership